Ontology highlight
ABSTRACT:
SUBMITTER: Kushner P
PROVIDER: S-EPMC5384506 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Women's health (London, England) 20160229 3
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, such as canagliflozin, are used in patients with Type 2 diabetes mellitus (T2DM). In clinical studies, canagliflozin significantly reduced A1C, bodyweight and blood pressure, and was generally well tolerated with no increased risk of hypoglycemia. Most common adverse effects observed were genital mycotic infections and urinary tract infections, and increased urination. Approximately 10% of women treated with canagliflozin experienced a genital ...[more]